KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Investing Activities (2016 - 2025)

Encompass Health (EHC) has disclosed Cash from Investing Activities for 17 consecutive years, with -$239.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 17.53% year-over-year to -$239.4 million, compared with a TTM value of -$764.6 million through Dec 2025, down 17.04%, and an annual FY2025 reading of -$764.6 million, down 17.04% over the prior year.
  • Cash from Investing Activities was -$239.4 million for Q4 2025 at Encompass Health, down from -$201.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$95.6 million in Q1 2021 and bottomed at -$239.4 million in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$165.7 million, with a median of -$161.8 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities tumbled 145.39% in 2021, then skyrocketed 45.49% in 2022.
  • Year by year, Cash from Investing Activities stood at -$220.7 million in 2021, then increased by 6.48% to -$206.4 million in 2022, then decreased by 0.82% to -$208.1 million in 2023, then increased by 2.11% to -$203.7 million in 2024, then fell by 17.53% to -$239.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for EHC at -$239.4 million in Q4 2025, -$201.3 million in Q3 2025, and -$165.4 million in Q2 2025.